TENX

Tenax Therapeutics, Inc. [TENX] Stock Forecast

Q: What is Tenax Therapeutics, Inc. stock symbol ?

Tenax Therapeutics, Inc. is a US stock, located in Morrisville of Nc and trading under the symbol TENX

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

TENX Stock Summary

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 100.28%

Does not have any significance market cap ($5.13M)

TENX has less than 1 year of cash runway

Top 10 Correlated Stocks

TENX

In the News

07:52 04 Feb 2023 TENX

Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?

Tenax Therapeutics (NASDAQ: TENX ) stock is rocketing higher on Thursday after getting an update on one of its patents. That includes a Notice of Allowance from the USPTO.

11:01 04 Feb 2023 TENX

Why Is Tenax Therapeutics (TENX) Stock On the Move Today?

Tenax Therapeutics (NASDAQ: TENX ) stock is on the move Wednesday after the company announced plans for a reverse stock split. At 5:00 p.m.

02:00 04 Feb 2023 TENX

7 Cheap Penny Stocks To Buy For Under $1 Right Now

Penny stocks under $1: Are they worth the risk to buy right now? The post 7 Cheap Penny Stocks To Buy For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:40 04 Feb 2023 TENX

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX

New York, New York--(Newsfile Corp. - July 16, 2021) - Levi & Korsinsky announces it has commenced an investigation of Tenax Therapeutics, Inc (NASDAQ: TENX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/tenax-therapeutics-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

07:56 04 Feb 2023 TENX

TENX Stock Price Increases Over 12% Pre-Market: Why It Happened

The stock price of Tenax Therapeutics Inc (NASDAQ: TENX) increased by over 12% pre-market. This is why it happened.

04:52 04 Feb 2023 TENX

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX

New York, New York--(Newsfile Corp. - June 7, 2021) - Levi & Korsinsky announces it has commenced an investigation of Tenax Therapeutics, Inc (NASDAQ: TENX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/tenax-therapeutics-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

05:15 04 Feb 2023 TENX

Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX) announces first quarter 2021 financial results and provides business update.

10:52 04 Feb 2023 TENX

Tenax Therapeutics Stock Price Increased Over 35% Intraday: Why It Happened

The stock price of Tenax Therapeutics (NASDAQ: TENX) increased by over 35% during intraday trading. This is why it happened.

04:45 04 Feb 2023 TENX

Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis have voluntarily agreed to step down from the Board of Directors.

04:45 04 Feb 2023 TENX

Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX) today reported financial results for the year ended December 31, 2020 and provided a business update

TENX Financial details

Company Rating

Neutral

Market Cap

5.13M

Income

-11.71M

Revenue

Book val./share

0.15

Cash/share

0.14

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

27 Mar 2023

P/E

-3.94

Forward P/E

PEG

-0.66

P/S

P/B

11.65

P/C

12.5

P/FCF

-3.69

Quick Ratio

5.52

Current Ratio

6.54

Debt / Equity

0.02

LT Debt / Equity

0.02

EPS (TTM)

2.12

EPS next Y

EPS next Q

EPS this Y

-218.94%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

SMA20

-9.25%

SMA50

-8.44%

SMA100

-50.72%

Inst Own

25.9%

Inst Trans

1.26%

ROA

-247%

ROE

-282%

ROC

1.31%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

2.29M

Shs Float

2.18M

Target Price

52W Range

1.6-17.0

52W High

-89.71%

52W Low

+75%

RSI

40.05

Rel Volume

21.09

Avg Volume

356.93K

Volume

7.53M

Perf Week

-17.06%

Perf Month

-36.13%

Perf Quarter

-70.74%

Perf Half Y

-66.86%

Beta

2.12592

Volatility

0.21%, 0.24%

Prev Close

-20.81%

Price

1.75

Change

-57.32%

TENX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Revenue per share	0	0	0	0	0
Net income per share	-6.27	-4.35	-1.35	1.33	-1.58
Operating cash flow per share	-8.61	-3.51	-1.22	-1.25	-0.53
Free cash flow per share	-8.61	-3.52	-1.22	-1.25	-0.53
Cash per share	5.48	8.22	0.87	0.91	0.27
Book value per share	6.3	7.52	0.61	0.62	0.21
Tangible book value per share	6.3	7.52	0.61	0.96	0.21
Share holders equity per share	6.3	7.52	0.61	0.62	0.21
Interest debt per share	0	0	0.02	0.02	0.01
Market cap	9.03M	1.83M	8.43M	17.06M	13.19M
Enterprise value	7.42M	-10.54M	3.63M	10.99M	7.9M
P/E ratio	-1.02	-0.27	-1	1.73	-0.41
Price to sales ratio	0	0	0	0	0
POCF ratio	-0.74	-0.33	-1.12	-1.84	-1.21
PFCF ratio	-0.74	-0.33	-1.11	-1.84	-1.21
P/B Ratio	1.02	0.16	2.23	3.69	3.11
PTB ratio	1.02	0.16	2.23	3.69	3.11
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	-0.84	1.55	-0.44	1.1	-0.24
EV to operating cash flow	-0.61	1.92	-0.48	-1.18	-0.73
EV to free cash flow	-0.61	1.91	-0.48	-1.18	-0.73
Earnings yield	-0.98	-3.72	-1	0.58	-2.46
Free cash flow yield	-1.35	-3.01	-0.9	-0.54	-0.82
Debt to equity	0	0	0	0	0.04
Debt to assets	0.1	0.12	0.41	0.02	0.29
Net debt to EBITDA	0.18	1.82	0.58	-0.61	0.16
Current ratio	7.99	8.51	2.44	3.21	3.64
Interest coverage	0	0	0	-6.07K	-34.49K
Income quality	1.37	0.81	0.9	-0.94	0.33
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.33	-0.84	-0.03	-0.03	-0.05
Stock based compensation to revenue	0	0	0	0	0
Graham number	29.8	27.15	4.31	4.32	2.71
ROIC	-1.04	-0.59	-2.23	-1.92	-7.39
Return on tangible assets	-0.89	-0.51	-1.32	1.36	-5.42
Graham Net	4.79	7.22	0.45	0.89	0.19
Working capital	7.05M	11.75M	3.65M	4.68M	4.13M
Tangible asset value	0	0	0	0	0
Net current asset value	7.05M	11.75M	3.59M	6.67M	3.94M
Invested capital	0	0	0.03	0.04	0.07
Average receivables	0	0	0	0	0
Average payables	684.86K	753.84K	1.21M	757.86K	808.75K
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	-1	-0.58	-2.23	2.13	-7.65
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric	2021-09-30	2021-12-31	2022-03-31	2022-06-30	2022-09-30
Revenue per share	0	0	0	0	0
Net income per share	-0.15	-0.13	-0.11	-0.11	-0.11
Operating cash flow per share	-0.12	-0.11	-0.12	-0.14	-0.13
Free cash flow per share	-0.12	-0.11	-0.12	-0.14	-0.13
Cash per share	0.33	0.22	0.11	0.29	0.14
Book value per share	0.29	0.17	0.06	0.27	0.15
Tangible book value per share	0.29	0.17	0.06	0.27	0.15
Share holders equity per share	0.29	0.17	0.06	0.27	0.15
Interest debt per share	0.01	0.01	0.02	0.01	0.01
Market cap	44.61M	26.21M	20.42M	7.56M	4.48M
Enterprise value	36.57M	20.92M	18.04M	663.81K	881.31K
P/E ratio	-2.94	-2.04	-1.88	-0.66	-0.38
Price to sales ratio	0	0	0	0	0
POCF ratio	-14.76	-9.47	-6.95	-2.2	-1.34
PFCF ratio	-14.75	-9.46	-6.94	-2.2	-1.34
P/B Ratio	6.16	6.17	12.71	1.11	1.13
PTB ratio	6.16	6.17	12.71	1.11	1.13
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	-9.69	-6.57	-6.7	-0.23	-0.31
EV to operating cash flow	-12.1	-7.56	-6.14	-0.19	-0.26
EV to free cash flow	-12.1	-7.55	-6.13	-0.19	-0.26
Earnings yield	-0.09	-0.12	-0.13	-0.38	-0.65
Free cash flow yield	-0.07	-0.11	-0.14	-0.45	-0.74
Debt to equity	0.03	0.04	0.1	0.02	0.02
Debt to assets	0.19	0.29	0.57	0.19	0.17
Net debt to EBITDA	2.13	1.66	0.88	2.44	1.24
Current ratio	5.87	3.64	1.75	5.6	6.54
Interest coverage	0	0	1.05K	1.93K	7.84K
Income quality	0.8	0.86	1.08	1.2	1.14
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.06	-0.06	-0.23	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.99	0.69	0.39	0.83	0.61
ROIC	-0.51	-0.73	1.54	0.41	0.72
Return on tangible assets	-0.43	-0.54	-0.73	-0.34	-0.62
Graham Net	0.27	0.15	0.03	0.22	0.11
Working capital	7.12M	4.13M	1.48M	6.66M	3.82M
Tangible asset value	0	0	0	0	0
Net current asset value	6.91M	3.94M	1.32M	6.53M	3.73M
Invested capital	0.04	0.07	0.31	0.05	0.05
Average receivables	0	0	0	0	0
Average payables	847.82K	889.51K	1.1M	919.38K	592.4K
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	-0.52	-0.76	-1.69	-0.42	-0.74
Capex per share	0	0	0	0	0

TENX Frequently Asked Questions

What is Tenax Therapeutics, Inc. stock symbol ?

Tenax Therapeutics, Inc. is a US stock , located in Morrisville of Nc and trading under the symbol TENX

What is Tenax Therapeutics, Inc. stock quote today ?

Tenax Therapeutics, Inc. stock price is $1.75 today.

Is Tenax Therapeutics, Inc. stock public?

Yes, Tenax Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 356.93K
Market Capitalization 5.13M
Employee 8
CEO Mr. Christopher T. Giordano
Headquarters Morrisville,NC,US
IPO Date 1993-10-28
Website https://www.tenaxthera.com

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.